Loading...
Successful Treatment of a Patient with anti-PD1 Antibody-Resistant Advanced Mucosal Melanoma with Nivolumab, Ipilimumab plus Denosumab Combination Therapy
Since the incidence of mucosal melanoma is higher in the Japanese population compared to Caucasians, and since mucosal melanoma possesses a lower mutation burden compared to cutaneous melanoma, the efficacy of anti-PD1 antibody (Ab) monotherapy for mucosal melanoma is limited. Therefore, other targe...
Na minha lista:
| Udgivet i: | Case Rep Oncol |
|---|---|
| Main Authors: | , , , , , , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
S. Karger AG
2020
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7154272/ https://ncbi.nlm.nih.gov/pubmed/32308589 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1159/000506327 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|